Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone

PHASE3CompletedINTERVENTIONAL
Enrollment

798

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Schizophrenic Disorders
Interventions
DRUG

Quetiapine XR

Oral, once daily, tablets of 400 mg to 800 mg

DRUG

Risperidone

Oral, once daily, tablets of 2 mg to 6 mg

Trial Locations (116)

Unknown

Research Site, Assebroek

Research Site, Hasselt

Research Site, Liège

Research Site, Montignies-sur-Sambre

Research Site, Roeselare

Research Site, Sint-Denijs-Westrem

Research Site, Tournai

Research Site, Fortaleza

Research Site, Salvador

Research Site, Aparecida de Goiânia

Research Site, Belo Horizonte

Research Site, Curitiba

Research Site, Recife

Research Site, Rio de Janeiro

Research Site, Porto Alegre

Research Site, Itapira

Research Site, Ribeirão Preto

Research Site, São Paulo

Research Site, Sorocaba

Research Site, Botucatu

Research Site, Cerova Koria Village

Research Site, Pazardzhik

Research Site, Pleven

Research Site, Plovdiv

Research Site, Sofia

Research Site, Stara Zagora

Research Site, Varna

Research Site, Barrio Los Yoses

Research Site, Curridabat

Research Site, Guadalupe

Research Site, Helsinki

Research Site, Kitee

Research Site, Kuopio

Research Site, Lapua

Research Site, Pori

Research Site, Raahe

Research Site, Rovaniemi

Research Site, Tampere

Research Site, Turku

Research Site, Bad Saarow

Research Site, Berlin

Research Site, Bielefeld

Research Site, Bochum

Research Site, Butzbach

Research Site, Cologne

Research Site, Darmstadt

Research Site, Duisburg

Research Site, Gelsenkirchen

Research Site, Grevenbroich

Research Site, Hamburg

Research Site, Hattingen

Research Site, Hildesheim

Research Site, Königsbrück

Research Site, Mittweida

Research Site, München

Research Site, Oranienburg

Research Site, Siegen

Research Site, Stralsund

Research Site, Wismar

Research Site, Andria

Research Site, Feltre

Research Site, Maddaloni

Research Site, Sora

Research Site, Genova

Research Site, Milan

Research Site, Perugia

Research Site, Fidenza

Research Site, Parma

Research Site, Palmi

Research Site, Rimini

Research Site, Salerno

Research Site, Sassari

Research Site, Chioggia

Research Site, Ancona

Research Site, Pompei

Research Site, México

Research Site, México

Research Site, Monterrey, Nuevo Leon

Research Site, San Luis Potosí City

Research Site, Guadalajara Jalisco

Research Site, México

Research Site, Yucatán

Research Site, Abraveses

Research Site, Braga

Research Site, Coimbra

Research Site, Lisbon

Research Site, Porto

Research Site, Santarém

Research Site, Piteşti

Research Site, Galati

Research Site, Bucharest

Research Site, Craiova

Research Site, Sibiu

Research Site, Moscow

Research Site, Kazan'

Research Site, Moscow

Research Site, Saint Petersburg

Research Site, Jaén

Research Site, Málaga

Research Site, Seville

Research Site, Zamudio (vizcaya)

Research Site, Salamanca

Research Site, Zamora

Research Site, Mataro (barcelona)

Research Site, Vigo

Research Site, Madrid

Research Site, Langreo

Research Site, Elche (alicante)

Research Site, Sant Joan d'Alacant

Research Site, Prilly

Research Site, Wil

Research Site, Istanbul

Research Site, Manisa

Research Site, Ankara

Research Site, Elâzığ

Research Site, Izmir

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY